Purpose: Pigs expressing neither galactose-a1,3-galactose (Gal) nor N-glycolylneuraminic acid (NeuGc) take xenotransplantation one step closer to the clinic. Our aims were (1) to document the lack of NeuGc expression on corneas and aortas and cultured endothelial cells [aortic endothelial cells (AECs); corneal (CECs)] of GTKO/ NeuGcKO pigs, and (2) to investigate whether the absence of NeuGc reduced human antibody binding to the tissues and cells.
T he production of a1,3-galactosyltransferase geneknockout (GTKO) pigs in 2003 was a significant advance in the development of xenotransplantation. 1 In 2013, pigs that lacked 2 major carbohydrate xenoantigens, galactose-a1,3-galactose (Gal) and N-glycolylneuraminic acid (NeuGc), were introduced (GTKO/NeuGcKO pigs). 2 The absence of expression of NeuGc (NeuGcKO pigs) further reduced the xenoantigenicity of pig peripheral blood mononuclear cells (PBMCs) when exposed to human serum, because a significant fraction of human anti-non-Gal antibodies is known to be specific for carbohydrate structures with terminal NeuGc. 3 Most pig organs, except neural tissue, express NeuGc, 4 and the extent of expression is similar to, or greater than, that of the Gal antigen. 5 Furthermore, almost all healthy humans develop anti-NeuGc antibodies, 3, 6 in part due to exposure to dietary NeuGc. 7 For the purposes of clinical xenotransplantation, the need to delete expression of NeuGc was first suggested by Bouhours et al 8 in 1996 . In 2013, the first GTKO/NeuGcKO pigs were successfully produced by zinc-finger nuclease technology. 2 Binding of human serum IgM and IgG to GTKO/NeuGcKO pig PBMCs was significantly reduced when compared with binding to GTKO pig PBMCs. 2, 9 However, there is no definitive report using other primary cultured cells so far. We have now investigated NeuGc expression on wild-type (WT) and GTKO pig corneas and aortas and have compared IgM and IgG antibody binding to these tissues.
The cornea is an unusual tissue in terms of its immunologic features, for example, avascularity, weak expression of major histocompatibility complex antigens, and presence of immunomodulating molecules in the aqueous humor. 10 Despite these advantageous features, the antigenicity of the pig cornea remains a major barrier to successful xenotransplantation. Nevertheless, the immunologic characteristics of corneas may be different from those of other organs.
Production of both anti-Gal 11 and anti-non-Gal 12 antibody production has been reported in the pig-to-monkey corneal transplantation model, especially when the graft is rejected. Human patients grafted with pig skin 13 or ligaments 14 develop high titers of anti-non-Gal antibodies. The expression of the sialic acids, N-acetylneuraminic (NeuAc) acid and NeuGc, varies between different pig tissues and cells. These oligosaccharides can be present as glycoprotein or glycolipid. 5 Previously, we reported the presence and distribution of Gal and NeuGc on WT and GTKO porcine corneas by immunofluorescence staining. 15 Gal is mainly expressed on the stromal keratocytes (and weakly on the stroma), with no expression on the corneal epithelium or endothelium in naive status (ie, when the cornea is not activated). However, WT pig corneal endothelial cells (CECs) develop Gal epitopes in certain situations (eg, during in vitro culture, 16 or when exposed to inflammatory cytokines after xenotransplantation). 17 In contrast to Gal, NeuGc is expressed on the corneal epithelium and endothelium in addition to stromal keratocytes. 18 Because healthy CECs are essential to corneal transparency, and thus good vision, after corneal transplantation, they represent the most important structures. Antibody binding to the CECs may result in significant injury.
Our aims in the present study were (1) to document the absence of Gal and NeuGc expression on the cornea and aorta, as well as on cultured cells, from GTKO/NeuGcKO pigs, (2) 
MATERIALS AND METHODS

Preparation of Corneas
All procedures used in this study conformed to the ARVO Statement for the Use of Animals in Ophthalmic and Vision Research. In addition, all in vitro human study protocols were approved by the Research Ethics Committee at the University of Pittsburgh. The samples were obtained in accordance with the Declaration of Helsinki. Participants gave informed consent per the guidelines of the Institutional Review Board of the University of Pittsburgh (IRB0608179).
Eyes from 6-month-old WT (Large White) pigs (n = 3) were obtained from a local slaughterhouse. Eyes from GTKO pigs (on a Large White background) were obtained from Revivicor (Blacksburg, VA) (n = 3) and from GTKO pigs (on a mixed background, NSRRC; 0009) from the National Swine Resource and Research Center (NSRRC, Columbia, MO) (n = 2). All GTKO pigs were naturally bred offspring, with the original founder pigs derived from nuclear transfer/ embryo transfer.
Eyes from GTKO/NeuGcKO pigs (by zinc-finger nuclease technology on a Yorkshire/Chester White background) were provided by the Department of Surgery, Indiana University School of Medicine (Indianapolis, IN) (n = 2), and eyes from GTKO/NeuGcKO pigs (by nuclear transfer/embryo transfer on a Large White background) were provided by Revivicor (n = 6).
Corneas from deceased humans (blood type O) that were not suitable for clinical transplantation were provided by the Pittsburgh Center for Organ Recovery and Education (CORE) with approval of the University of Pittsburgh Committee for Oversight of Research Involving the Dead (CORID No. 231) and in accordance with the guidelines of the Declaration of Helsinki for research involving the use of human tissues. 16 
Preparation of Cultured CECs
The eye globes were maintained in sterile wet gauze until the corneas were excised (with at least 1 mm of surrounding sclera). From each pair of corneas, one was embedded in optimal cutting temperature compound (Tissue-Tek; Miles Laboratories, Naperville, IL), frozen, and sectioned for immunofluorescence staining. The other provided CECs. Pig and human CECs were isolated, cultured, and passaged as previously described 19 and used after passage 2 to 4.
Preparation of Aortas and Cultured AECs
Thoracic aortas from all of the above-mentioned pigs were obtained, and pig (p) AECs were cultured and passaged as previously described. 20 All cells were cultured in collagen-I-coated 25-or 75-cm 2 tissue culture flasks (BD Biosciences, San Jose, CA).
Immunofluorescence Staining for Gal and NeuGc on Corneas and Aortas
Staining for expression of Gal and NeuGc was performed as previously described. 15 Gal staining was performed with fluorescein isothiocyanate (FITC)-conjugated BSI-B4 lectin (isolectin B4 from Bandeiraea simplicifolia; 10 mg/mL; Sigma-Aldrich, St Louis, MO). NeuGc staining was performed with a chicken-derived anti-NeuGc immunohistochemistry kit (Sialix, Cambridge, MA), following the manufacturer's instructions. DAPI (4,6-diamidino-2-phenylindole) (Invitrogen, Waltham, MA) stained nuclei in all cases.
Immunofluorescence Staining for Human IgM and IgG Binding to Corneas and Aortas
IgM and IgG binding assays using human serum were performed as previously described. 15 Heat-inactivated pooled serum from healthy human volunteers (n = 5, including all ABO blood types) was diluted to 20% for IgM and to 5% for IgG binding. Corneal or aortic tissues were incubated with pooled human serum for 60 minutes at room temperature. Phosphate-buffered serum (PBS) (Invitrogen) was used as a negative control. The slides were then washed with PBS and blocked with 10% goat serum for 30 minutes at room temperature. FITC-conjugated goat-derived anti-human IgM (m-chain-specific) or IgG (g-chain-specific) polyclonal antibody (concentration 1:100; Invitrogen) was applied for 30 minutes at room temperature for detection of IgM or IgG binding. DAPI was applied for nuclear staining, and the slides were examined by fluorescence microscopy (Nikon, Tokyo, Japan).
Flow Cytometric Analysis for Gal and NeuGc Expression on and Human IgM/IgG Binding to Cultured CECs and AECs
Surface expression of Gal and NeuGc, and human IgM/ IgG binding to CECs and AECs were detected by flow cytometry (BD LSR II; BD Biosciences), as previously described. 16 Serum samples from healthy human volunteers (n = 7, including all ABO blood types) were pooled. CECs or AECs were diluted to 10 5 cells per tube in flow cytometry buffer (PBS containing 1% BSA and 0.1% NaN 3 ). The antibodies used for immunofluorescence staining were also used for the detection of antibody binding shown as relative MFI (rMFI).
Statistical Methods
Statistical significance of differences was determined by Student's t or nonparametric tests, as appropriate, using GraphPad Prism version 4 (GraphPad Software, San Diego, CA). Values are presented with mean value. Differences were considered to be significant at P , 0.05.
RESULTS
Expression of Gal and NeuGc by Immunofluorescence or Flow Cytometry
The tissue structure and cell morphology of corneas from genetically-engineered pigs, including GTKO/NeuGcKO pigs, were not different from those of WT pigs 21 (data not shown). WT pig corneas and aortas expressed Gal (Figs. 1A, C) and NeuGc (Figs. 1B, C) as did CECs (Figs. 2A, B) . GTKO pig corneas and aortas (from pigs of 2 different genetic backgrounds) were negative for Gal expression, but positive for NeuGc (Figs. 1A-C) , as were GTKO CECs (Figs.  2A, B) and AECs (Figs. 2C, D) .
Flow cytometry revealed that the expression level of NeuGc on CECs from GTKO pigs from the NSRRC was higher than on CECs from GTKO pigs from Revivicor and WT corneas [the relative mean fluorescence intensity (rMFI) of 2 NSRRC pigs was 9.7 and 21.6, respectively, and of 3 Revivicor pigs, 4.3, 6.3, and 4.4, respectively (Fig.  3A) ], although statistical analysis could not be performed because of the small number of corneas tested. Similar to CECs, the expression level of NeuGc on AECs from the NSRRC was higher than on AECs of GTKO pigs from Revivicor and WT aortas (Fig. 3B) . GTKO/NeuGcKO pig corneas, aortas (Fig. 1), cultured pCECs (Figs. 2A, B) and pAECs (from both sources, Figs. 2C, D) did not express either Gal or NeuGc, as was the case of human corneas and CECs (Figs. 1, 2) .
Human IgM and IgG Antibody Binding to Corneas and Aortas by Immunofluorescence
Compared to binding to WT pig corneas, human IgM and IgG binding to GTKO pig corneas was decreased (Figs. 4A, B) . Fluorescence intensity appeared even less in GTKO/NeuGcKO pig corneas, particularly in the endothelium, but there was still some binding when compared with human corneas (Figs. 4A, B) . Human IgM and IgG bound primarily to the endothelium of pig aortic tissue (Fig. 4C ) and seemed to be related to expression of NeuGc epitopes. Compared with binding to WT pig aortas, binding of human IgM and IgG to GTKO pig aortas were greatly decreased, especially in the endothelium, and it was further decreased in GTKO/NeuGcKO pig aortas (Fig. 4C) . 
Human IgM and IgG Antibody Binding to CECs and AECs by Flow Cytometry
Binding of human IgM and IgG to GTKO pCECs was greatly reduced compared with that to WT pCECs (Figs. 5A, B) . There was no obvious difference in human IgM/IgG binding to the CECs from GTKO pigs (from 2 different genetic backgrounds) and GTKO/NeuGcKO pigs (from 2 different genetic backgrounds). In contrast to pCECs, there was significant further reduction of human IgM/IgG binding to GTKO/NeuGcKO pAECs in comparison with GTKO pAECs (Figs. 5C, D) . There was no significant difference in binding to pAECs from both types of GTKO pigs or GTKO/ NeuGcKO pigs.
DISCUSSION
Neither Gal nor NeuGc could be detected in corneas/ CECs (or aortas/AECs) from GTKO/NeuGcKO pigs, as is the case with human corneas and aortas. Nevertheless, some human antibodies, noticeably IgG, bound to the corneas and aortas, which suggests that there are remaining xenoantigens on GTKO/NeuGcKO pig corneas and aortas, as suggested by others. 22 An antibody directed to non-Gal/non-NeuGc antigens has been proposed, 23 but its specificity remains unknown. Byrne et al have identified b1,4 N-acetylgalactosaminyltransferase as an antigen of significance in xenotransplantation, 24 but its relevance to corneal transplantation is unknown. Whether antibody binding to non-Gal, non-NeuGc and AECs (C and D) by flow cytometry using different individual human sera. A, Human IgM binding to WT pCECs was variable, but binding to GTKO and GTKO/NeuGcKO pig CECs and to human CECs was significantly decreased (n = 6, *P , 0.05). Binding of the human IgM antibody to human CECs was significantly lower than to all other pCECs (*P , 0.05). There was no significant difference in binding to GTKO and GTKO/NeuGcKO pCECs. B, Human IgG binding to WT CECs was variable, but binding to GTKO, GTKO/NeuGcKO, or human CECs was significantly decreased (n = 6, *P , 0.05). There was no significant difference in binding to GTKO, GTKO/NeuGcKO, and human CECs. C, Human IgM binding to WT pAECs was variable, but binding to GTKO and GTKO/NeuGcKO pAECs was significantly decreased (n = 6, *P , 0.05). There was no significant difference in IgM binding to pAECs from GTKO pigs of 2 different genetic backgrounds, but binding to GTKO pAECs was significantly greater than to GTKO/NeuGcKO pAECs (*P , 0.05; ns, not significant). There was no significant difference in IgM binding to pAECs from GTKO/NeuGcKO pigs of 2 different genetic backgrounds. Binding of the human IgM antibody to human CECs was significantly lower than to all other pCECs (*P , 0.05). D, Human IgG binding to WT and GTKO pAECs and was variable, but almost no binding to GTKO/NeuGcKO pAECs was detected. Compared with WT pAECs, human IgG binding to GTKO and GTKO/NeuGcKO pAECs was significantly decreased (n = 6, *P , 0.05). There was no significant difference in IgG binding to GTKO pAECs of 2 different genetic backgrounds, but binding to GTKO pAECs was significantly greater than to GTKO/NeuGcKO pAECs (*P , 0.05; ns, not significant). There was no significant difference in IgG binding to pAECs from GTKO/NeuGcKO pigs of 2 different genetic backgrounds.
epitopes on a corneal graft (or other organs) would be detrimental to its long-term outcome needs to be investigated.
A higher expression of NeuGc has been demonstrated in GTKO pig tissue (ie, heart, liver, kidney) and cells (fibroblast cells) compared with NeuGc expression on WT cells, which suggests that deletion of the a1,3-galactosyltransferase gene leads to a "compensatory" increased expression of sialylated glycans, including NeuGc. 25, 26 In contrast, in our previous experience, we did not document any difference in expression of NeuGc between WT and GTKO pig corneas by immunofluorescence staining. 15 However, in the present study, by flow cytometry, we detected varying levels of expression of NeuGc depending on the genetic background of the pig. Cells (both pAECs and pCECs) from the GTKO pigs provided by the NSRRC seemed to have greater expression of NeuGc than WT pigs, but cells from GTKO pigs provided by Revivicor showed similar or even lower expression than did WT pigs, but whether this difference is significant remains uncertain. Expression of NeuGc would need to be measured in various strains of pig using a quantifiable method.
These perceived different levels of NeuGc expression did not correlate with the extent of human antibody binding. Pigs from the NSRRC had higher NeuGc expression, but human antibody binding to the tissues or cells was not more than to those from Revivicor pigs. The variable level of NeuGc expression on pCECs and pAECs may therefore not be sufficiently different to show disparity in antibody binding. The differing backgrounds (strains) of the pigs or different techniques of genetic modification may have modified the composition of surface carbohydrate. The extent of antibody binding may also be influenced by the presence of anti-nonGal, anti-non-NeuGc antibodies in the serum.
When using CECs as the target cells, there were no significant differences in human IgM or IgG binding to GTKO and GTKO/NeuGcKO CECs. There was minimal antibody binding to CECs from either GTKO or GTKO/ NeuGcKO pigs; nevertheless, the binding of IgM was significantly higher than to human cells. There was no binding of IgG to all GTKO, GTKO/NeuGcKO, and human cells (rMFI # 1). This result differs from that reported using PBMCs 2,9 and AECs as target cells, which showed greater reduction in antibody binding to GTKO/NeuGcKO pig cells than to GTKO pig cells. This may possibly be explained by low immunogenicity of pig CECs compared with that of pig PBMCs and AECs. 16 Both Gal 16 and NeuGc expression are significantly lower on CECs than on comparable AECs [mean rMFI of the NeuGc level of pAECs = 142.3 6 145.1 (n = 7) vs. mean rMFI of the NeuGc level of pCECs = 9.2 6 6.0 (n = 7); P = 0.02]. Removal of Gal epitopes alone seems to be sufficient to significantly reduce the humoral barrier to CECs, but not to AECs.
Whether human anti-NeuGc antibodies are less or more detrimental to a pig graft than anti-Gal antibodies is uncertain. Although human anti-NeuGc antibodies have a lower IgM/ IgG ratio and lower titers of the preexisting natural antibody, the presence of NeuGc epitopes on the pig corneal endothelium (where Gal is absent) may be important and may be associated with greater injury. 4 The in vivo human-elicited antibody response to NeuGc has not been measured, but may be considerable, thus initiating rejection. Furthermore, the interactions of NeuGc with circulating anti-NeuGc antibodies may potentially incite inflammation, 27 and therefore the absence of NeuGc may reduce both humoral and inflammatory barriers to corneal xenotransplantation. Long-term assessment of the relationship between NeuGc and inflammation will be necessary.
In summary, by reducing human xenoreactive antibody binding, the development of pigs deficient in both Gal and NeuGc may reduce immunologic and/or inflammatory injury to a pig corneal xenograft in humans (but not in Old World nonhuman primates, which express NeuGc), but will not prevent all antibody binding. Identification and deletion of other xenoantigens may be necessary to provide complete protection of a pig corneal xenograft.
